Roivant Sciences ROIV Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Roivant Sciences in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Roivant Sciences’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Roivant Sciences's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Roivant Sciences's total liabilities & equity?
- Roivant Sciences (ROIV) reported total liabilities & equity of $5.71B in Q1 2026.
- How has Roivant Sciences's total liabilities & equity changed year-over-year?
- Roivant Sciences's total liabilities & equity increased by 5.0% year-over-year, from $5.44B to $5.71B.
- What is the long-term trend for Roivant Sciences's total liabilities & equity?
- Over 5 years (2020 to 2025), Roivant Sciences's total liabilities & equity has grown at a 17.1% compound annual growth rate (CAGR), from $2.59B to $5.71B.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.